Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Efficacy of Liver Fibrosis and Steatosis Assessment With Fibroscan and iLivTouch in Patients With Chronic Liver Diseases

NCT05224037 is registered in ClinicalTrials.gov with Federal State Budgetary Scientific Institution as lead sponsor.

NCT NCT05224037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05224037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Efficacy of Liver Fibrosis and Steatosis Assessment With Fibroscan and iLivTouch in Patients With Chronic Liver Diseases
Lead sponsor
Federal State Budgetary Scientific Institution
Phase
Not applicable
Overall status
Completed
Start date
January 21, 2022
Completion date
December 31, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic liver disease, liver fibrosis, liver steatoses